X-Ceptor

Caldan Therapeutics

The company develops small-molecule drugs targeting free fatty acid receptors to treat metabolic diseases, such as type 2 diabetes, for the pharmaceutical industry.

Shifa

This biopharmaceutical company develops oral small molecule drugs to treat cardiovascular disease and dyslipidemia for patients with high cholesterol.

Xterna

The company develops enhanced nucleic acids to provide targeted drug delivery solutions for pharmaceutical and biotechnology researchers seeking to treat previously inaccessible diseased tissues.

CV Therapeutics

This biopharmaceutical company develops and commercialises small molecule drugs for patients with cardiovascular diseases, including chronic angina and myocardial perfusion imaging needs.

Melacure Therapeutics AB

This biotechnology company develops small molecule drugs targeting melanocortin receptors to treat metabolic, inflammatory and skin disorders for the pharmaceutical industry.

Esperion Therapeutics Inc

This company develops and commercialises oral cholesterol-lowering medicines for patients with hyperlipidaemia or at risk of cardiovascular disease.

NewAmsterdam Pharma

The company develops oral therapies to lower cholesterol in patients with cardiovascular disease whose symptoms are inadequately managed by standard statin treatments.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.